文献速递认知障碍与痴呆

睡眠呼吸障碍与社区老年人阿尔茨海默病生物标志物的关联

Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial.
PubMed 文献 · JAMA Neurol · 2020-01-01

本研究为Age-Well随机临床试验的二次分析,纳入127名认知正常的社区老年人,比较有无睡眠呼吸障碍(SDB)者的多模态神经影像。结果显示SDB与后扣带回和楔前叶区域淀粉样蛋白沉积增加及灰质体积、灌注和代谢改变相关,但与认知或睡眠症状无关。

要点

  • SDB与AD敏感脑区淀粉样蛋白沉积及神经元活动改变相关。
  • SDB相关脑改变主要位于后扣带回和楔前叶。
  • 认知正常老年人中SDB相关脑改变无症状,支持筛查治疗。

核心结论

  • 认知正常老年人中SDB与AD敏感脑区淀粉样蛋白沉积增加及神经元活动改变相关。

研究设计与样本

  • 横断面研究,基于Age-Well随机临床试验数据,2016-2018年法国Caen的Cyceron中心采集。
  • 纳入127名完成神经心理评估、多导睡眠图、磁共振及florbetapir和FDG PET的社区老年人。
  • 以呼吸暂停低通气指数15次/小时为界分类SDB,进行体素组间比较。

主要发现

  • SDB组淀粉样蛋白负荷更高(t114=4.51;FWE校正P=.04;Cohen d=0.83)。
  • SDB组灰质体积(t119=4.12;FWE校正P=.04;Cohen d=0.75)、灌注(t116=4.62;FWE校正P=.001;Cohen d=0.86)和代谢(t79=4.63;FWE校正P=.001;Cohen d=1.04)存在差异。
  • 上述脑改变主要重叠于后扣带回和楔前叶。
  • 未发现SDB与认知、自报认知/睡眠困难或日间过度嗜睡症状的关联。

临床怎么用

  • 对认知正常老年人应考虑筛查SDB,以降低阿尔茨海默病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Increasing evidence suggests that sleep-disordered breathing (SDB) increases the risk of developing Alzheimer clinical syndrome. However, the brain mechanisms underlying the link between SDB and Alzheimer disease are still unclear. OBJECTIVE: To determine which brain changes are associated with the presence of SDB in older individuals who are cognitively unimpaired, including changes in amyloid deposition, gray matter volume, perfusion, and glucose metabolism. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was conducted using data from the Age-Well randomized clinical trial of the Medit-Ageing European project, acquired between 2016 and 2018 at Cyceron Center in Caen, France. Community-dwelling older adults were assessed for eligibility and were enrolled in the Age-Well clinical trial if they did not meet medical or cognitive exclusion criteria and were willing to participate. Participants who completed a detailed neuropsychological assessment, polysomnography, a magnetic resonance imaging, and florbetapir and fluorodeoxyglucose positron emission tomography scans were included in the analyses. MAIN OUTCOMES AND MEASURES: Based on an apnea-hypopnea index cutoff of 15 events per hour, participants were classified as having SDB or not. Voxelwise between-group comparisons were performed for each neuroimaging modality, and secondary analyses aimed at identifying which SDB parameter (sleep fragmentation, hypoxia severity, or frequency of respiratory disturbances) best explained the observed brain changes and assessing whether SDB severity and/or SDB-associated brain changes are associated with cognitive and behavioral changes. RESULTS: Of 157 participants initially assessed, 137 were enrolled in the Age-Well clinical trial, and 127 were analyzed in this study. The mean (SD) age of the 127 participants was 69.1 (3.9) years, and 80 (63.0%) were women. Participants with SDB showed greater amyloid burden (t114 = 4.51; familywise error-corrected P = .04; Cohen d, 0.83), gray matter volume (t119 = 4.12; familywise error-corrected P = .04; Cohen d, 0.75), perfusion (t116 = 4.62; familywise error-corrected P = .001; Cohen d, 0.86), and metabolism (t79 = 4.63; familywise error-corrected P = .001; Cohen d, 1.04), overlapping mainly over the posterior cingulate cortex and precuneus. No association was found with cognition, self-reported cognitive and sleep difficulties, or excessive daytime sleepiness symptoms. CONCLUSIONS AND RELEVANCE: The SDB-associated brain changes in older adults who are cognitively unimpaired include greater amyloid deposition and neuronal activity in Alzheimer disease-sensitive brain regions, notably the posterior cingulate cortex and precuneus. These results support the need to screen and treat for SDB, especially in asymptomatic older populations, to reduce Alzheimer disease risk. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02977819.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. André C, Rehel S, Kuhn E, et al. Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial. JAMA Neurol. 2020. PMID: 32202593. doi:10.1001/jamaneurol.2020.0311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。